Regulation of the metastatic cell phenotype by sialylated glycans
about
The Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer ProgressionTargeting Selectins and Their Ligands in CancerGlycotherapy: new advances inspire a reemergence of glycans in medicineEnzymatic Basis for N-Glycan Sialylation: STRUCTURE OF RAT 2,6-SIALYLTRANSFERASE (ST6GAL1) REVEALS CONSERVED AND UNIQUE FEATURES FOR GLYCAN SIALYLATIONProtein glycosylation in cancers and its potential therapeutic applications in neuroblastomaThe Role of Sialyl-Tn in CancerReversal effect of ST6GAL 1 on multidrug resistance in human leukemia by regulating the PI3K/Akt pathway and the expression of P-gp and MRP1Discovery of specific metastasis-related N-glycan alterations in epithelial ovarian cancer based on quantitative glycomicsMALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarraysStable Ectopic Expression of ST6GALNAC5 Induces Autocrine MET Activation and Anchorage-Independence in MDCK CellsAdvancement of Sialyltransferase Inhibitors: Therapeutic Challenges and OpportunitiesThe Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell PhenotypeSialyl-tn in cancer: (how) did we miss the target?Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide.Sialic acid linkage differentiation of glycopeptides using capillary electrophoresis - electrospray ionization - mass spectrometryCarbohydrate-to-carbohydrate interactions between α2,3-linked sialic acids on α2 integrin subunits and asialo-GM1 underlie the bone metastatic behaviour of LNCAP-derivative C4-2B prostate cancer cellsTransforming growth factor beta receptor 2 (TGFBR2) changes sialylation in the microsatellite unstable (MSI) Colorectal cancer cell line HCT116Epigenetic inactivation of ST6GAL1 in human bladder cancer.Exploration of sialic acid diversity and biology using sialoglycan microarrays.Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissuesActivation of protein kinase C-α and Src kinase increases urea transporter A1 α-2, 6 sialylation.Workflow for combined proteomics and glycomics profiling from histological tissuesIdentification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells.Antibodies against Escherichia coli O24 and O56 O-Specific Polysaccharides Recognize Epitopes in Human Glandular Epithelium and Nervous Tissue.Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinomaBlood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients.Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells.MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.Nutrient-deprived cancer cells preferentially use sialic acid to maintain cell surface glycosylation.Expression of N-Acetylglucosaminyltransferase III Suppresses α2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to α2,6-Sialylation Levels.Mechanism and inhibition of human UDP-GlcNAc 2-epimerase, the key enzyme in sialic acid biosynthesis.Onco-Golgi: Is Fragmentation a Gate to Cancer Progression?ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells.Integrated Transcriptomic and Glycomic Profiling of Glioma Stem Cell Xenografts.Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.Aptamer-Mediated Transparent-Biocompatible Nanostructured Surfaces for Hepotocellular Circulating Tumor Cells Enrichment.Variation in Carbohydrates between Cancer and Normal Cell Membranes Revealed by Super-Resolution Fluorescence Imaging.Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast Carcinoma.Altered tumor-cell glycosylation promotes metastasis.O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer.
P2860
Q26750877-BAD8E63A-E063-44A0-ABDE-00920205E788Q26752384-F661820B-9634-4967-97FB-237DE52E576EQ27027997-DD4127C9-46FF-4443-998F-E73C79CCBFD5Q27680447-ADEA514F-1EBA-4812-BE7F-435D7B2B0CB6Q28069952-1E08F415-C0F7-46FB-AE98-B3C3DEC4BC26Q28075448-A63BF86A-E587-409F-8CD7-28883365F206Q28538781-E53F45BA-DD90-45C9-8332-201AEB8309E0Q28539618-B9AFE10B-1389-4DC2-A825-3622A27FC83EQ28542741-EE803C05-4E50-4A18-8D23-C51270543710Q28553147-52FA2372-6211-4378-8485-10926224AD75Q30039640-6EC73B61-EBA9-461A-9A0E-5C0E32F08720Q30276749-5FAB4DCA-3B38-46FE-A6EA-800A05B8EF3EQ33649572-A94DE07B-49E0-4456-8C18-75C58A8AB11FQ33650423-41FB59D1-30B0-4D0D-97C4-8EDF8E089B5EQ33807752-379E2F3E-82D1-4BEB-B546-F666A7B3FEB5Q34197482-D0001320-B86F-48B2-8031-344F9A93CA7CQ34611732-3A6933C0-D90D-4878-8009-CE8B3DE91334Q34695132-241140ED-6F27-4D21-B445-0278804BF9ECQ34772126-C004CF02-F486-4016-8C74-E275E06ED3A4Q34992443-C5E5A7F8-BF2E-4769-B0D4-43D3C4509F2CQ35228540-2A05F4CC-FEB6-4918-8A41-F117F6749E57Q35592825-EA4BA5FA-44AC-4D95-B4E3-3F71A699FFF7Q35615401-1290AEEF-046C-4AD9-906E-2F05ADD9238FQ35667157-C05328FA-D225-46D3-B487-8799B594161EQ35836524-48F27FEB-E8CD-4754-8E32-B670509DA54EQ36169039-DC0F0174-CA27-4B71-A14A-733C88F5BFFAQ36226902-20AE95B9-78BA-47F9-B82C-8D0E57FDDF3CQ36256730-598331A4-A9C7-4AED-BA67-6FFF331BA4E8Q36315969-27154A2F-95E3-4467-8933-C1E1855BE2A9Q36674650-44FD1F8B-EAE9-47A9-8E15-7A1208E09AB4Q36690880-F1F289FB-1EC0-4887-8E15-75602FB23CECQ36776494-310949EC-D9D6-4C7E-8642-B7B894EDABBCQ36798320-9142E586-2E67-4666-96B0-D9A210B62146Q37029570-1619BB75-5785-4615-B7FD-9BDAD0A0458DQ37174016-1DFBF024-3C74-43C2-B498-814B92320483Q37202310-D8DC33AE-A87C-4B59-8ECA-21F9C6B97308Q37505096-67830334-0627-4C1E-B3B8-04A9C8F0D172Q37541987-2D0C0FC6-7A31-4BA4-9C90-D691480A92D4Q37581540-9171E487-71D8-4FEA-AAD2-F9FE01BF6BA8Q37696344-38A09310-411F-4BEB-883C-FFAC290510D2
P2860
Regulation of the metastatic cell phenotype by sialylated glycans
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Regulation of the metastatic cell phenotype by sialylated glycans
@ast
Regulation of the metastatic cell phenotype by sialylated glycans
@en
Regulation of the metastatic cell phenotype by sialylated glycans
@nl
type
label
Regulation of the metastatic cell phenotype by sialylated glycans
@ast
Regulation of the metastatic cell phenotype by sialylated glycans
@en
Regulation of the metastatic cell phenotype by sialylated glycans
@nl
prefLabel
Regulation of the metastatic cell phenotype by sialylated glycans
@ast
Regulation of the metastatic cell phenotype by sialylated glycans
@en
Regulation of the metastatic cell phenotype by sialylated glycans
@nl
P2093
P2860
P3181
P1476
Regulation of the metastatic cell phenotype by sialylated glycans
@en
P2093
Amanda F. Swindall
Matthew J. Schultz
Susan L. Bellis
P2860
P2888
P304
P3181
P356
10.1007/S10555-012-9359-7
P407
P577
2012-12-01T00:00:00Z
P6179
1029252143